4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate

C89H104N14O19 — CID 157228220

IUPAC4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate
SMILESC=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(=O)O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1.C=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(C)=O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1
InChIInChI=1S/C45H53N7O9.C44H51N7O10/c1-6-20-60-45(57)52-36-25-37(28(2)23-33(36)43(56)51-19-9-7-12-34(51)44(52)61-40-14-8-10-21-59-40)58-22-11-13-39(54)47-38-27-50(5)41(48-38)42(55)46-32-17-15-30(16-18-32)31-24-35(29(3)53)49(4)26-31;1-5-19-60-44(57)51-33-24-35(27(2)22-31(33)41(54)50-18-8-6-11-32(50)42(51)61-38-13-7-9-20-59-38)58-21-10-12-37(52)46-36-26-49(4)39(47-36)40(53)45-30-16-14-28(15-17-30)29-23-34(43(55)56)48(3)25-29/h6,15-18,23-27,34,40,44H,1,7-14,19-22H2,2-5H3,(H,46,55)(H,47,54);5,14-17,22-26,32,38,42H,1,6-13,18-21H2,2-4H3,(H,45,53)(H,46,52)(H,55,56)/t34-,40?,44?;32-,38?,42?/m00/s1
InChIKeyATUKLRIHFGFBGS-CVBNTDAESA-N
MW1673.89 g/mol
LogP13.48
Rot. Bonds28

About 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate

4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate (PubChem CID 157228220) has the molecular formula C89H104N14O19 and a molecular weight of 1673.89 g/mol. Its IUPAC name is 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate.

Molecular Properties

Compound Name4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate
PubChem CID157228220
Molecular FormulaC89H104N14O19
Molecular Weight1673.89 g/mol
Exact Mass1672.76
IUPAC Name4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate
SMILESC=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(=O)O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1.C=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(C)=O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1
InChIInChI=1S/C45H53N7O9.C44H51N7O10/c1-6-20-60-45(57)52-36-25-37(28(2)23-33(36)43(56)51-19-9-7-12-34(51)44(52)61-40-14-8-10-21-59-40)58-22-11-13-39(54)47-38-27-50(5)41(48-38)42(55)46-32-17-15-30(16-18-32)31-24-35(29(3)53)49(4)26-31;1-5-19-60-44(57)51-33-24-35(27(2)22-31(33)41(54)50-18-8-6-11-32(50)42(51)61-38-13-7-9-20-59-38)58-21-10-12-37(52)46-36-26-49(4)39(47-36)40(53)45-30-16-14-28(15-17-30)29-23-34(43(55)56)48(3)25-29/h6,15-18,23-27,34,40,44H,1,7-14,19-22H2,2-5H3,(H,46,55)(H,47,54);5,14-17,22-26,32,38,42H,1,6-13,18-21H2,2-4H3,(H,45,53)(H,46,52)(H,55,56)/t34-,40?,44?;32-,38?,42?/m00/s1
InChIKeyATUKLRIHFGFBGS-CVBNTDAESA-N
XLogP13.48
TPSA371.35 Ų
H-Bond Donors5
H-Bond Acceptors24
Rotatable Bonds28
Heavy Atoms122
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001673.89
LogP ≤ 513.48
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate?
The IUPAC name of 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate (CID 157228220) is 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate.
What is the SMILES notation for 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate?
The canonical SMILES for 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate is C=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(=O)O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1.C=CCOC(=O)N1c2cc(OCCCC(=O)Nc3cn(C)c(C(=O)Nc4ccc(-c5cc(C(C)=O)n(C)c5)cc4)n3)c(C)cc2C(=O)N2CCCC[C@H]2C1OC1CCCCO1.
What is the InChIKey of 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate?
The InChIKey is ATUKLRIHFGFBGS-CVBNTDAESA-N. The full InChI is InChI=1S/C45H53N7O9.C44H51N7O10/c1-6-20-60-45(57)52-36-25-37(28(2)23-33(36)43(56)51-19-9-7-12-34(51)44(52)61-40-14-8-10-21-59-40)58-22-11-13-39(54)47-38-27-50(5)41(48-38)42(55)46-32-17-15-30(16-18-32)31-24-35(29(3)53)49(4)26-31;1-5-19-60-44(57)51-33-24-35(27(2)22-31(33)41(54)50-18-8-6-11-32(50)42(51)61-38-13-7-9-20-59-38)58-21-10-12-37(52)46-36-26-49(4)39(47-36)40(53)45-30-16-14-28(15-17-30)29-23-34(43(55)56)48(3)25-29/h6,15-18,23-27,34,40,44H,1,7-14,19-22H2,2-5H3,(H,46,55)(H,47,54);5,14-17,22-26,32,38,42H,1,6-13,18-21H2,2-4H3,(H,45,53)(H,46,52)(H,55,56)/t34-,40?,44?;32-,38?,42?/m00/s1.
What are the key properties of 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate?
4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate has a molecular weight of 1673.89 g/mol, XLogP of 13.48, 28 rotatable bonds, 5 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[[4-[4-[[(6aS)-2-methyl-6-(oxan-2-yloxy)-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]phenyl]-1-methylpyrrole-2-carboxylic acid;prop-2-enyl (6aS)-3-[4-[[2-[[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylimidazol-4-yl]amino]-4-oxobutoxy]-2-methyl-6-(oxan-2-yloxy)-12-oxo-6,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepine-5-carboxylate is sourced from PubChem (CID 157228220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).